Published in J Clin Microbiol on June 30, 2010
Molecular methods and platforms for infectious diseases testing a review of FDA-approved and cleared assays. J Mol Diagn (2011) 1.10
Evaluation of the Gen-Probe Aptima HIV-1 RNA qualitative assay as an alternative to Western blot analysis for confirmation of HIV infection. J Clin Microbiol (2011) 0.94
Evaluation of pooling strategies for acute HIV-1 infection screening using nucleic acid amplification testing. J Clin Microbiol (2011) 0.84
Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS (2003) 11.66
Detection of acute infections during HIV testing in North Carolina. N Engl J Med (2005) 7.60
Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med (2004) 5.78
Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008. Arch Intern Med (2010) 2.28
Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States. J Clin Microbiol (2008) 1.97
Sensitivity of HCV RNA and HIV RNA blood screening assays. Transfusion (2002) 1.15
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med (2012) 20.03
Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med (2008) 7.71
Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection. Sci Transl Med (2010) 5.85
Complete protection from repeated vaginal simian-human immunodeficiency virus exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine. J Virol (2009) 4.73
Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS (2004) 4.17
Clinical features and management of intraorbital foreign bodies. Ophthalmology (2002) 4.03
A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. AIDS (2007) 3.58
Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006. J Am Acad Dermatol (2011) 3.11
Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes. AIDS Res Hum Retroviruses (2010) 2.86
Periocular and orbital amyloidosis: clinical characteristics, management, and outcome. Ophthalmology (2006) 2.80
Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis (2004) 2.70
Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008. Arch Intern Med (2010) 2.28
Gene expression analysis of host innate immune responses during Lethal H5N1 infection in ferrets. J Virol (2008) 2.23
Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D Levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population. Clin Infect Dis (2011) 2.00
Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin Infect Dis (2013) 1.94
Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Ann Intern Med (2015) 1.86
Management of myogenic ptosis. Ophthalmology (2002) 1.82
Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. J Infect Dis (2003) 1.80
Progress in prevention of mother-to-child transmission of HIV in New York State: 1988-2008. J Public Health Manag Pract (2010) 1.80
Investigation of false positive results with an oral fluid rapid HIV-1/2 antibody test. PLoS One (2007) 1.80
Racial and ethnic variations in incidence and survival of cutaneous melanoma in the United States, 1999-2006. J Am Acad Dermatol (2011) 1.76
Orbital metastasis: clinical features, management and outcome. Orbit (2009) 1.73
High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy. Clin Infect Dis (2010) 1.58
Durable protection from vaginal simian-human immunodeficiency virus infection in macaques by tenofovir gel and its relationship to drug levels in tissue. J Virol (2011) 1.56
Management of Marcus Gunn jaw winking synkinesis. Ophthal Plast Reconstr Surg (2004) 1.54
Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). Drug Alcohol Depend (2007) 1.50
Population-based biochemistry, immunologic and hematological reference values for adolescents and young adults in a rural population in Western Kenya. PLoS One (2011) 1.47
Trends in perimortal conditions and mortality rates among HIV-infected patients. AIDS (2007) 1.43
When to begin highly active antiretroviral therapy? Evidence supporting initiation of therapy at CD4+ lymphocyte counts <350 cells/microL. Clin Infect Dis (2003) 1.42
Imidazo-pyrazine derivatives as potent CXCR3 antagonists. Bioorg Med Chem Lett (2009) 1.40
Trends in pregnancy rates among women with human immunodeficiency virus. Obstet Gynecol (2004) 1.40
Differences in prescription of antiretroviral therapy in a large cohort of HIV-infected patients. J Acquir Immune Defic Syndr (2003) 1.39
Rapid HIV screening: missed opportunities for HIV diagnosis and prevention. J Clin Virol (2012) 1.38
Natural substrate concentrations can modulate the prophylactic efficacy of nucleotide HIV reverse transcriptase inhibitors. J Virol (2011) 1.38
Identification of KIF21A mutations as a rare cause of congenital fibrosis of the extraocular muscles type 3 (CFEOM3). Invest Ophthalmol Vis Sci (2004) 1.36
Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy. AIDS (2006) 1.30
Clinical features and management of tumors affecting the lacrimal drainage apparatus. Ophthal Plast Reconstr Surg (2006) 1.29
CD28 disruption exacerbates inflammation in Tgf-beta1-/- mice: in vivo suppression by CD4+CD25+ regulatory T cells independent of autocrine TGF-beta1. Blood (2004) 1.28
Orbital and adnexal sarcoidosis. Arch Ophthalmol (2007) 1.24
Ongoing sexually transmitted disease acquisition and risk-taking behavior among US HIV-infected patients in primary care: implications for prevention interventions. Sex Transm Dis (2012) 1.23
Evaluation of dried blood spot specimens for HIV-1 drug-resistance testing using the Trugene HIV-1 genotyping assay. J Clin Virol (2008) 1.23
Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US. Antivir Ther (2012) 1.22
Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study). Sex Transm Dis (2011) 1.21
Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006. J Am Acad Dermatol (2011) 1.20
Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort. AIDS (2014) 1.19
Progression of carotid intima-media thickness in a contemporary human immunodeficiency virus cohort. Clin Infect Dis (2011) 1.18
Virologic and immunologic response to antiretroviral therapy and predictors of HIV type 1 drug resistance in children receiving treatment in Abidjan, Côte d'Ivoire. AIDS Res Hum Retroviruses (2008) 1.17
CTLA-4 overexpression inhibits T cell responses through a CD28-B7-dependent mechanism. J Immunol (2006) 1.15
Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay. J Clin Virol (2011) 1.15
HIV-1 RNA rectal shedding is reduced in men with low plasma HIV-1 RNA viral loads and is not enhanced by sexually transmitted bacterial infections of the rectum. J Infect Dis (2011) 1.15
Protection against rectal transmission of an emtricitabine-resistant simian/human immunodeficiency virus SHIV162p3M184V mutant by intermittent prophylaxis with Truvada. J Virol (2011) 1.11
Lacrimal outflow dysgenesis. Ophthalmology (2004) 1.10
Evaluation of an alternative supplemental testing strategy for HIV diagnosis by retrospective analysis of clinical HIV testing data. J Clin Virol (2011) 1.07
Antagonism of chemokine receptor CXCR3 inhibits osteosarcoma metastasis to lungs. Int J Cancer (2009) 1.04
Postexposure protection of macaques from vaginal SHIV infection by topical integrase inhibitors. Sci Transl Med (2014) 1.03
Novel simian foamy virus infections from multiple monkey species in women from the Democratic Republic of Congo. Retrovirology (2012) 1.03
Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation. Cancer Discov (2011) 1.02
Measuring environmental change in forest ecosystems by repeated soil sampling: a north american perspective. J Environ Qual (2013) 1.02
Idiopathic sclerosing orbital inflammation. Arch Ophthalmol (2006) 1.00
Prevalence of sexually acquired antiretroviral drug resistance in a community sample of HIV-positive men who have sex with men in New York City. AIDS Patient Care STDS (2011) 1.00
Prevalence of drug-resistance mutations and non-subtype B strains among HIV-infected infants from New York State. J Acquir Immune Defic Syndr (2006) 1.00
Chemerin connects fat to arterial contraction. Arterioscler Thromb Vasc Biol (2013) 0.99
Accessory protein 5a is a major antagonist of the antiviral action of interferon against murine coronavirus. J Virol (2010) 0.97
Orbital roof fractures: management of ophthalmic complications. Ophthal Plast Reconstr Surg (2003) 0.97
HIV sexual transmission risk among serodiscordant couples: assessing the effects of combining prevention strategies. AIDS (2014) 0.97
Performances on the CogState and standard neuropsychological batteries among HIV patients without dementia. AIDS Behav (2011) 0.96
Reasons for lack of appropriate receipt of primary Pneumocystis jiroveci pneumonia prophylaxis among HIV-infected persons receiving treatment in the United States: 1994-2003. Clin Infect Dis (2007) 0.96
Management of periocular basal cell carcinoma with modified en face frozen section controlled excision. Ophthal Plast Reconstr Surg (2002) 0.95
Positron emission tomography in the detection and staging of ocular adnexal lymphoproliferative disease. Ophthalmology (2006) 0.95
Treatment and outcomes of malignant melanoma of the eyelid: a review of 29 cases in Australia. Ophthalmology (2006) 0.93
Impact on hemoglobin of starting combination antiretroviral therapy with or without zidovudine in anemic HIV-infected patients. J Acquir Immune Defic Syndr (2008) 0.93
HIV-infected injection drug users: health care utilization and morbidity. J Health Care Poor Underserved (2007) 0.93
Blepharophimosis: a recommendation for early surgery in patients with severe ptosis. Clin Experiment Ophthalmol (2003) 0.93
Periocular keratoacanthoma: clinical features, pathology, and management. Ophthalmology (2003) 0.93
Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice. Proc Natl Acad Sci U S A (2002) 0.92
Quantification of HIV-1 p24 by a highly improved ELISA: an alternative to HIV-1 RNA based treatment monitoring in patients from Abidjan, Côte d'Ivoire. J Clin Virol (2006) 0.92
Plasmablastic lymphoma in the orbit: case report. Orbit (2008) 0.92
Sadness in the SUN: using computerized screening to analyze correlates of depression and adherence in HIV-infected adults in the United States. AIDS Patient Care STDS (2012) 0.91
Resistance to Simian HIV infection is associated with high plasma interleukin-8, RANTES and Eotaxin in a macaque model of repeated virus challenges. J Acquir Immune Defic Syndr (2010) 0.91
The management of perineural spread of squamous cell carcinoma to the ocular adnexae. Ophthal Plast Reconstr Surg (2003) 0.91
Cerebrospinal fluid leaks in orbital and lacrimal surgery. Surv Ophthalmol (2008) 0.90
Dirofilarial infection of the orbit. Orbit (2003) 0.88
Short communication: The Veterans Aging Cohort Study Index is an effective tool to assess baseline frailty status in a contemporary cohort of HIV-infected persons. AIDS Res Hum Retroviruses (2015) 0.88
Low bone mineral density and risk of incident fracture in HIV-infected adults. Antivir Ther (2015) 0.87
HIV screening practices in U.S. hospitals, 2009-2010. Public Health Rep (2012) 0.87
Evaluation of a multiplex assay for estimation of HIV-1 incidence. PLoS One (2013) 0.87
Characterization of HIV-1 subtypes and drug resistance mutations among individuals infected with HIV in Georgia. J Med Virol (2012) 0.87
Acidification in the Adirondacks: defining the biota in trophic levels of 30 chemically diverse acid-impacted lakes. Environ Sci Technol (2010) 0.87
Ocular adnexal pseudo-cyst formation as a characteristic feature of perineural spread in squamous cell carcinoma. Ophthal Plast Reconstr Surg (2006) 0.86
Eosinophilic angiocentric fibrosis: an unusual entity producing complete lacrimal duct obstruction. Orbit (2006) 0.86
Missed connections: HIV-infected people never in care. Public Health Rep (2013) 0.85